Literature DB >> 16421708

[Practical pain control in pediatric oncology. Recommendations of the German Society of Pediatric Oncology and Hematology, the German Association for the Study of Pain, the German Society of Palliative Care, and the Vodafone Institute of Children's Pain Therapy and Palliative Care].

B Zernikow1, C Schiessl, C Wamsler, G Janssen, N Griessinger, R Fengler, F Nauck.   

Abstract

In pediatric oncology, optimal pain control is still a challenge. A structured pain history and the regular scoring of pain intensity using age-adapted measuring tools are hallmarks of optimal pain control. Psychological measures are as important as drug therapy in the prophylaxis or control of pain, especially when performing invasive procedures. Pain control is oriented toward the WHO multistep therapeutic schedule. On no account should the pediatric patient have to climb up the "analgesic ladder" - strong pain requires the primary use of strong opioids. Give opioids preferably by the oral route and by the clock - short-acting opioids should be used to treat breakthrough pain. Alternatives are i.v. infusion, patient-controlled analgesia, and transdermal applications. Constipation is the adverse effect most often seen with (oral) opioid therapy. Adverse effects should be anticipated, and prophylactic treatment should be given consistently. The assistance of pediatric nurses is of the utmost importance in pediatric pain control. Nurses deliver the basis for rational and effective pain control by scoring pain intensity and documenting drug administration as well as adverse effects. The nurses' task is also to prepare the patient for and monitor the patient during painful procedures. It is the responsibility of both nurse and doctor to guarantee emergency intervention during sedation whenever needed. In our guideline we comment on drug selection and dosage, pain measurement tools, and documentation tools for the purpose of pain control. Those tools may be easily integrated into daily routine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421708     DOI: 10.1007/s00482-005-0459-y

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  41 in total

Review 1.  Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.

Authors:  T E Wilens; J Biederman; R J Baldessarini; B Geller; D Schleifer; T J Spencer; B Birmaher; A Goldblatt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-11       Impact factor: 8.829

Review 2.  [Meperidine (pethidine) outdated as analgesic in acute pancreatitis].

Authors:  T van Voorthuizen; J H Helmers; M M Tjoeng; M H Otten
Journal:  Ned Tijdschr Geneeskd       Date:  2000-04-01

3.  Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity.

Authors:  K Allegaert; B J Anderson; R Verbesselt; A Debeer; J de Hoon; H Devlieger; J N Van Den Anker; D Tibboel
Journal:  Br J Anaesth       Date:  2005-06-10       Impact factor: 9.166

4.  The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: a double-blind, prospective, randomized, controlled study.

Authors:  Lynne G Maxwell; Sandra C Kaufmann; Sally Bitzer; Eric V Jackson; John McGready; Sabine Kost-Byerly; Lori Kozlowski; Sharon K Rothman; Myron Yaster
Journal:  Anesth Analg       Date:  2005-04       Impact factor: 5.108

5.  Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.

Authors:  F R Sallee; L Nesbitt; C Jackson; L Sine; G Sethuraman
Journal:  Am J Psychiatry       Date:  1997-08       Impact factor: 18.112

6.  Tolerance and analgesic efficacy of a new i.v. paracetamol solution in children after inguinal hernia repair.

Authors:  I Murat; C Baujard; C Foussat; E Guyot; H Petel; B Rod; C Ricard
Journal:  Paediatr Anaesth       Date:  2005-08       Impact factor: 2.556

7.  Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.

Authors:  J J Collins; J Geake; H E Grier; C S Houck; H T Thaler; H J Weinstein; N Y Twum-Danso; C B Berde
Journal:  J Pediatr       Date:  1996-11       Impact factor: 4.406

8.  Effects of buprenorphine on motor activity of the sphincter of Oddi in man.

Authors:  J C Cuer; M Dapoigny; S Ajmi; J L Larpent; B Lunaud; C Ferrier; G Bommelaer
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

9.  The analgesic efficacy of an injectable prodrug of acetaminophen in children after orthopaedic surgery.

Authors:  J C Granry; B Rod; J P Monrigal; J Merckx; J Berniere; N Jean; E Boccard
Journal:  Paediatr Anaesth       Date:  1997       Impact factor: 2.556

10.  Opioid rotation in children with cancer.

Authors:  Ross Drake; Judith Longworth; John J Collins
Journal:  J Palliat Med       Date:  2004-06       Impact factor: 2.947

View more
  3 in total

1.  [Special pediatric care for dying children. IMPaCCT determines the standards for pediatric palliative care in Germany].

Authors:  B Zernikow
Journal:  Schmerz       Date:  2008-08       Impact factor: 1.107

Review 2.  [Differential indications of opioids in pain therapy].

Authors:  J Heyn; S C Azad
Journal:  Anaesthesist       Date:  2017-11       Impact factor: 1.041

Review 3.  Pediatric palliative care: use of opioids for the management of pain.

Authors:  Boris Zernikow; Erik Michel; Finella Craig; Brian J Anderson
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.